Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Meinicke, Y. Darcan, G. Fels, U. Wahn, W. Henke, E. Hamelmann (Berlin, Germany). Improvement of allergic asthma symptoms by targeting STAT6 with siRNA. Eur Respir J 2008; 32: Suppl. 52, 3190

Member's Comments

No comment yet.

Related content which might interest you: New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Severity of allergic rhinitis and asthma control Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 TNFAIP3/A20 expression in allergic asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Association of asthma control with allergic rhinitis severity in adult patients Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019 Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005 Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT) Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Specific immunotherapy in the management of allergic asthma Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management Year: 2008 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Impact of allergic rhinitis on asthma Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy Year: 2012 Quality of life in children with asthma associated with allergic rhinitis Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009 The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004 Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2002; 20: 73-78 Year: 2002 Does treatment of allergic rhinitis with intranasal steroids improve asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Improved symptom relief with omalizumab in the treatment of allergic rhinitis Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis Source: Annual Congress 2013 –Asthma Year: 2013